Senti Biosciences Valuation
| SNTI Stock | USD 0.83 0.02 2.47% |
Today, the company appears to be undervalued. Senti Biosciences has a current Real Value of $3.49 per share. The regular price of the company is $0.83. Our model measures the value of Senti Biosciences from inspecting the company fundamentals such as Shares Owned By Institutions of 22.48 %, return on equity of -3.95, and Shares Outstanding of 26.29 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Senti Biosciences' valuation include:
Price Book 2.6935 | Enterprise Value | Enterprise Value Ebitda (0.28) | Price Sales 55.4557 | Enterprise Value Revenue 134.2161 |
Undervalued
Today
Please note that Senti Biosciences' price fluctuation is very risky at this time. Calculation of the real value of Senti Biosciences is based on 3 months time horizon. Increasing Senti Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Senti Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Senti Stock. However, Senti Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.83 | Real 3.49 | Target 11.5 | Hype 0.76 |
The intrinsic value of Senti Biosciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Senti Biosciences' stock price.
Estimating the potential upside or downside of Senti Biosciences helps investors to forecast how Senti stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Senti Biosciences more accurately as focusing exclusively on Senti Biosciences' fundamentals will not take into account other important factors: When choosing an evaluation method for Senti Biosciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Senti Biosciences Cash |
|
Senti Biosciences Total Value Analysis
Senti Biosciences is at this time anticipated to have valuation of 39.75 M with market capitalization of 21.87 M, debt of 33.64 M, and cash on hands of 140.78 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Senti Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
39.75 M | 21.87 M | 33.64 M | 140.78 M |
Senti Biosciences Asset Utilization
One of the ways to look at asset utilization of Senti is to check how much profit was generated for every dollar of assets it reports. Senti Biosciences has a negative utilization of assets of -0.68 %, losing $0.006777 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Senti Biosciences shows how discouraging it operates for each dollar spent on its assets.Senti Biosciences Profitability Analysis
Based on Senti Biosciences' profitability indicators, Senti Biosciences may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Senti Biosciences' ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -47.5 M | Current Value -49.9 M | Quarterly Volatility 16.9 M |
For Senti Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Senti Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Senti Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Senti Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Senti Biosciences over time as well as its relative position and ranking within its peers.
Senti Biosciences Earnings per Share Projection vs Actual
By analyzing Senti Biosciences' earnings estimates, investors can diagnose different trends across Senti Biosciences' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Senti Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Senti Biosciences Ownership Allocation
Senti Biosciences shows a total of 26.29 Million outstanding shares. Senti Biosciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Senti Biosciences Profitability Analysis
Net Loss for the year was (52.79 M) with loss before overhead, payroll, taxes, and interest of (37.6 M).About Senti Biosciences Valuation
An absolute valuation paradigm, as applied to Senti Stock, attempts to find the value of Senti Biosciences based on its fundamental and basic technical indicators. By analyzing Senti Biosciences's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Senti Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Senti Biosciences. We calculate exposure to Senti Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Senti Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.3 M | 2.4 M | |
| Pretax Profit Margin | (37.95) | (39.85) | |
| Operating Profit Margin | (42.19) | (44.30) | |
| Net Loss | (32.33) | (33.95) | |
| Gross Profit Margin | (152.88) | (160.53) |
Senti Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Senti Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Senti we look at many different elements of the entity such as Senti's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Senti Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Senti Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Senti Biosciences' worth.Complementary Tools for Senti Stock analysis
When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |